M2M – the 13th edition of the ‘From Molecule to Man’ Track – will explore the forefront of basic science and translational advances in Imaging and Therapy.
Since its introduction in 2014, the M2M sessions have become one of the central pillars of the EANM Annual Congress. The M2M Track fosters cross-disciplinary collaboration among the diverse scientific fields involved in molecular and nuclear imaging and therapy. By offering a platform that spans a broad spectrum of scientific and medical perspectives, the M2M sessions have evolved into a dynamic forum bringing together radiochemists, radiopharmacists, biologists, physicists, and clinicians, all contributing to the translation of fundamental discoveries into clinical applications.
The M2M Track features a carefully curated programme of invited lectures and scientific paper presentations designed to bridge fundamental research with unmet clinical needs. The EANM Committees for Translational Molecular Imaging & Therapy and Radiopharmaceutical Sciences jointly coordinate the scientific programme of the M2M Track.
We look forward to welcoming you to the M2M Track at EANM’26.
Tessa Buckle, EANM Translational Molecular Imaging & Therapy Committee
Harry Hendrikse, EANM Radiopharmaceutical Sciences Committee
Further information and session details will follow at the end of June 2026.